Ticker LaunchSPAC · Merger completed
TradeUP Acquisition Corp.
Business combination with Estrella Biopharma, Inc.
TradeUP Acquisition Corp. is a blank-check company (SPAC) that raised $40M in its initial public offering on Jul 19, 2021, listing on Nasdaq. It completed its business combination with Estrella Biopharma, Inc. on Sep 29, 2023; the combined company is Estrella Immunopharma, Inc. (ESLA). KeyBanc led the IPO. Hunter Taubman Fischer & Li advised the SPAC and Ellenoff Grossman & Schole advised the underwriters on the IPO.
Estrella Biopharma is a Delaware preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies. The therapies are aimed at patients with blood cancers and solid tumors.
- Status
- Merger completed
- IPO date
- Jul 19, 2021
- IPO size
- $40M
- IPO exchange
- Nasdaq
- Target
- Estrella Biopharma, Inc.
- Announced
- Oct 3, 2022
- Closed
- Sep 29, 2023
- Combined company
- Estrella Immunopharma, Inc. (ESLA)
- IPO underwriters
- KeyBanc
- SPAC counsel (IPO)
- Hunter Taubman Fischer & Li
- Underwriters' counsel (IPO)
- Ellenoff Grossman & Schole
More on this SPAC for subscribers
- Trust balance and value per share
- Redemptions at each extension and at the merger vote
- Liquidation deadline and extension history
- PIPE and other committed financing
- Merger proxy, registration statement and investor presentation
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Jul 19, 2021
- Deal announcement (8-K) Oct 3, 2022
- Press release
- All filings on EDGAR CIK 1844417
Other deSPACs that closed in 2023
- Falcon's Beyond Global, Inc.via FAST Acquisition Corp. II · closed Oct 5, 2023
- Cheche Group Inc.via Prime Impact Acquisition I · closed Oct 2, 2023
- Envoy Medical, Inc.via Anzu Special Acquisition Corp I · closed Sep 29, 2023
- NKGen Biotech, Inc.via Graf Acquisition Corp. IV · closed Sep 29, 2023
- New Nuvinivia Mercato Partners Acquisition Corp · closed Sep 29, 2023
- Conduit Pharmaceuticals Inc.via Murphy Canyon Acquisition Corp. · closed Sep 22, 2023